Screener
Inhibrx Biosciences, Inc. INBX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
FAQ
- What is Inhibrx Biosciences, Inc.'s enterprise value?
- Inhibrx Biosciences, Inc. (INBX) reported enterprise value of $1B in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s enterprise value changed year-over-year?
- Inhibrx Biosciences, Inc.'s enterprise value increased by 982.1% year-over-year, from $92.53M to $1B.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s enterprise value?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s enterprise value has grown at a 53.2% compound annual growth rate (CAGR), from $482.3M to $1.13B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Inhibrx Biosciences, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude